Your browser doesn't support javascript.
loading
Single-cell transcriptomics of human islet ontogeny defines the molecular basis of ß-cell dedifferentiation in T2D.
Avrahami, Dana; Wang, Yue J; Schug, Jonathan; Feleke, Eseye; Gao, Long; Liu, Chengyang; Naji, Ali; Glaser, Benjamin; Kaestner, Klaus H.
Afiliación
  • Avrahami D; Endocrinology and Metabolism Department, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.
  • Wang YJ; Department of Genetics and Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Schug J; Department of Genetics and Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Feleke E; Endocrinology and Metabolism Department, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.
  • Gao L; Department of Genetics and Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Liu C; Department of Surgery and Institute for Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Naji A; Department of Surgery and Institute for Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Glaser B; Endocrinology and Metabolism Department, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel. Electronic address: ben.glaser@mail.huji.ac.il.
  • Kaestner KH; Department of Genetics and Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. Electronic address: kaestner@pennmedicine.upenn.edu.
Mol Metab ; 42: 101057, 2020 12.
Article en En | MEDLINE | ID: mdl-32739450
ABSTRACT

OBJECTIVE:

Dedifferentiation of pancreatic ß-cells may reduce islet function in type 2 diabetes (T2D). However, the prevalence, plasticity and functional consequences of this cellular state remain unknown.

METHODS:

We employed single-cell RNAseq to detail the maturation program of α- and ß-cells during human ontogeny. We also compared islets from non-diabetic and T2D individuals.

RESULTS:

Both α- and ß-cells mature in part by repressing non-endocrine genes; however, α-cells retain hallmarks of an immature state, while ß-cells attain a full ß-cell specific gene expression program. In islets from T2D donors, both α- and ß-cells have a less mature expression profile, de-repressing the juvenile genetic program and exocrine genes and increasing expression of exocytosis, inflammation and stress response signalling pathways. These changes are consistent with the increased proportion of ß-cells displaying suboptimal function observed in T2D islets.

CONCLUSIONS:

These findings provide new insights into the molecular program underlying islet cell maturation during human ontogeny and the loss of transcriptomic maturity that occurs in islets of type 2 diabetics.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina / Desdiferenciación Celular Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Mol Metab Año: 2020 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina / Desdiferenciación Celular Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Mol Metab Año: 2020 Tipo del documento: Article País de afiliación: Israel